ELEVATE,急性肝卟啉症 (AHP) 患者登记处 (ELEVATE)
ELEVATE,一项针对急性肝卟啉症 (AHP) 患者的全球观察性纵向前瞻性登记
This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.
研究概览
地位
条件
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Alnylam Clinical Trial Information Line
- 电话号码:1-877-ALNYLAM
- 邮箱:clinicaltrials@alnylam.com
研究联系人备份
- 姓名:Alnylam Clinical Trial Information Line
- 电话号码:1-877-256-9526
- 邮箱:clinicaltrials@alnylam.com
学习地点
-
-
-
Taichung、台湾
- 招聘中
- Clinical Trial Site
-
Taipei、台湾
- 招聘中
- Clinical Trial Site
-
-
-
-
-
Berlin、德国
- 招聘中
- Clinical Trial Site
-
Chemnitz、德国
- 招聘中
- Clinical Trial Site
-
Würzburg、德国
- 招聘中
- Clinical Trial Site
-
-
-
-
-
Milan、意大利
- 招聘中
- Clinical Trial Site
-
Modena、意大利
- 招聘中
- Clinical Trial Site
-
-
-
-
-
Brussels、比利时
- 招聘中
- Clinical Trial Site
-
Leuven、比利时
- 招聘中
- Clinical Trial Site
-
-
-
-
-
Bordeaux、法国
- 招聘中
- Clinical Trial Site
-
Paris、法国
- 招聘中
- Clinical Trial Site
-
Toulouse、法国
- 招聘中
- Clinical Trial Site
-
-
-
-
-
Stockholm、瑞典
- 招聘中
- Clinical Trial Site
-
-
-
-
-
Zurich、瑞士
- 招聘中
- Clinical Trial Site
-
-
-
-
Alabama
-
Birmingham、Alabama、美国、35233
- 招聘中
- Clinical Trial Site
-
-
Arizona
-
Gilbert、Arizona、美国、85234
- 招聘中
- Clinical Trial Site
-
-
California
-
San Francisco、California、美国、90074
- 招聘中
- Clinical Trial Site
-
-
Maryland
-
Baltimore、Maryland、美国、21205
- 招聘中
- Clinical Trial Site
-
-
Massachusetts
-
Boston、Massachusetts、美国、02114
- 招聘中
- Clinical Trial Site
-
-
Minnesota
-
Minneapolis、Minnesota、美国、55455
- 招聘中
- Clinical Trial Site
-
-
New York
-
New York、New York、美国、10029
- 招聘中
- Clinical Trial Site
-
-
North Carolina
-
Winston-Salem、North Carolina、美国、27157
- 完全的
- Clinical Trial Site
-
-
Oklahoma
-
Oklahoma City、Oklahoma、美国、73120
- 完全的
- Clinical Trial Site
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19107
- 完全的
- Clinical Trial Site
-
-
Texas
-
Galveston、Texas、美国、77555
- 招聘中
- Clinical Trial Site
-
-
Utah
-
Salt Lake City、Utah、美国、84112
- 招聘中
- Clinical Trial Site
-
-
Washington
-
Seattle、Washington、美国、98195
- 招聘中
- Clinical Trial Site
-
-
-
-
-
Cardiff、英国
- 招聘中
- Clinical Trial Site
-
London、英国
- 招聘中
- Clinical Trial Site
-
-
-
-
-
Madrid、西班牙
- 招聘中
- Clinical Trial Site
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients with all types of AHP, including patients with hepatic and/or renal impairment, adolescents, elderly patient, and pregnant or lactating women.
描述
Inclusion Criteria:
- Documented diagnosis of AHP, per physician's determination
Exclusion Criteria:
- Currently enrolled in a clinical trial for any investigational agent
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
|---|
|
Patients with AHP
Patients with a diagnosis of AHP will be eligible for the study and will be managed and treated per routine clinical practice. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Incidence of Selected Events of Interest in AHP Patients
大体时间:Up to 6 years
|
Selected events of interest are defined as hepatic events (including hepatic neoplasia), renal events, thromboembolic events, and pancreatitis. |
Up to 6 years
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Annualized Rate of Porphyria Attacks
大体时间:Up to 6 years
|
Porphyria attacks are defined as meeting all of the following criteria: an acute episode of neurovisceral pain in the abdomen, back, chest, extremities and/or limbs, no other medically determined cause, and requires treatment with intravenous (IV) dextrose or hemin, carbohydrates, or analgesics, or other medications such as antiemetics at a dose or frequency beyond the participant's usual daily porphyria management. |
Up to 6 years
|
|
12-Item Short Form Health Survey Version 2 (SF-12 V2) (Standard Version)
大体时间:Up to 6 years
|
S-12 V2 is a 12-question measure capturing global quality of life and overall health status and evaluates the following 8 domains: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. |
Up to 6 years
|
合作者和调查者
调查人员
- 研究主任:Medical Director、Alnylam Pharmaceuticals
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.